Contact us
Please fill out the details below and we will get back to you shortly.
Thank you!
We will be contacting you soon..
Close
We will be contacting you soon..
Oops! Something went wrong while submitting the form.
Portal Instruments is pleased to be showcasing its latest drug delivery platform at the LSI conference in California next week. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact.
Portal Instruments will be showcasing its newest drug delivery platform at the prestigious Life Science Intelligence (LSI) conference in California next week. The company plans to showcase its latest injector platform, representing a significant advancement in reusable injectors. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact on the industry. This appearance at LSI marks an important milestone for Portal as it continues to expand its market presence and forge strategic partnerships within the healthcare ecosystem. Industry experts and potential investors are encouraged to schedule meetings with the Portal team to explore collaboration opportunities and witness firsthand how their innovations are addressing critical challenges in medical delivery systems.
September 2024 - Portal Instruments welcomes Matt Regan to its Board of Directors. Regan has held extensive leadership roles for prominent pharmaceutical companies such as Abbvie, Novo Nordisk and Micreos.
April 2021 - In the US, approximately 12% of women age 15 to 44 have trouble getting pregnant or carrying a pregnancy to term.¹ To honor National Infertility Week we sat down with Myra, an infertility nurse to talk about the hardships and joys associated with infertility treatment.
Portal Instruments today announced that it will further expand its partnership with Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, to commercialize the Prime NEXUS™ reusable, connected autoinjector platform.
Please fill out the details below and we will get back to you shortly.